Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana.
Villa G, Phillips RO, Smith C, et al
J Infect. 2018 Apr 24
Abstract

Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers.
Shaheen AA, AlMattooq M, Yazdanfar S, et al
Aliment Pharmacol Ther. 2017 Jul 13. 
Abstract

Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
Lee S, Ahn SH, Jung KS, Kim DY
 J Viral Hepat. 2016 Oct 20. doi
Abstract

Comparative renal safety assessment of the hepatitis B drugs, adefovir, tenofovir, telbivudine and entecavir in rats.
Uteng M, Mahl A, Beckmann N,
Toxicol Sci. 2016 Oct 13.
Abstract

Value of Cystatin C-Based e-GFR Measurements to Predict Long-Term Tenofovir Nephrotoxicity in Patients With Hepatitis B.
Koksal AR, Alkim H, Boga S, et al
Am J Ther. 2016 Oct 4
Abstract

FULL-TEXT ARTICLE
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Yim HJ.
Clin Mol Hepatol. 2016 Jun;22(2):238-40.
Paper

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial.
Sriprayoon T, Mahidol C, Ungtrakul T,  et al
Hepatol Res. 2016 May 13.
Abstract

FULL-TEXT ARTICLE
Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil.
Pereira CV, Tovo CV, Grossmann TK, et al
Mem Inst Oswaldo Cruz. 2016 Apr;111(4):252-7.
Paper

Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis.
Goyal SK, Dixit VK, Shukla SK,  et al
Indian J Gastroenterol. 2015 Aug 6
Abstract

Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
Fong TL, Tien A, Jo KJ,  et al
Dig Dis Sci. 2015 Jul 3.
Abstract

FULL-TEXT ARTICLE
Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients
Cho EJ, Lee JH, Cho Y,  et a
PLoS One. 2015 Jun 29;10(6):e0130392
Paper

Efficacy of Tenofovir-Based Rescue Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination.
Park JH, Jung SW, Park NH, et al 
Clin Ther. 2015 May 5.
Abstract

Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance.
Cho HJ, Kim SS, Shin SJ,  et al
J Med Virol. 2015 May 4.
Abstract

Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.
Lim YS, Yoo BC, Byun KS, et al
Gut. 2015 Mar 23. pii: gutjnl-2014-308435.
Abstract

Tenofovir versus entecavir in the treatment of chronic hepatitis B with severe acute exacerbation.
Hung CH, Hu TH, Lu SN,  et al
Antimicrob Agents Chemother. 2015 Mar 16. 
Abstract

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years.
Buti M, Fung S, Gane E,  et al
Hepatol Int. 2015 Mar 13.
Abstract

Effect of Entecavir and Tenofovir Treatment on Noninvasive Fibrosis Scores: Which One Is Better?
Koksal AR, Alkim H, Boga S, et al
Am J Ther. 2015 Feb 2
Abstract

FULL-TEXT ARTICLE
Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
Kim JH, Lee JS.
Korean J Intern Med. 2015 Jan;30(1):23-6.
Paper

FULL-TEXT  ARTICLE
Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China.
Huang M, Jie Y, Shi H, et al
Int J Clin Exp Med. 2015 Jan 15;8(1):666-73
Paper

Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.
Kim HJ, Cho JY, Kim YJ, et al
Korean J Intern Med. 2015 Jan;30(1):32-41.
Abstract

Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial.
Lim YS, Byun KS, Yoo BC,  et al
Gut. 2015 Jan 16. pii: gutjnl-2014-308353
Abstract

Effect of tenofovir with and without interferon on HDV replication in HIV-HBV-HDV infected patients.
Boyd A, Miailhes P, Brichler S, Scholtès C, et al
AIDS Res Hum Retroviruses. 2013 Aug 25
Abstract

Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
Buti M, Homs M.
Expert Rev Gastroenterol Hepatol. 2012 Aug;6(4):413-21.
Abstract

Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection.
Seto WK, Yuen MF, Fung J, Lai CL.
Hepatol Int. 2011 Jun 19
Abstract

Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient
with chronic hepatitis B and without genotypic hepatitis B virus resistance.
Sarrecchia C, Svicher V, Volpi A,  et al
Infection. 2011 Jun 15
Abstract

Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B:
A Systematic review.
Zhao SS, Tang LH, Dai XH, et al
Virol J. 2011 Mar 9;8(1):111.
Abstract
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with
decompensated chronic hepatitis B liver disease.
Liaw YF, Sheen IS, Lee CM,   et al
Hepatology. 2011 Jan;53(1):62-72.
Abstract